Study Analyzes Continuous Insulin Infusion, Oral Hypoglycemics Use in T2D
While continuous subcutaneous insulin infusion therapy (CSII) is commonly used in the management of type 1 diabetes, less is known about its use in patients with type 2 diabetes (T2D). Further, there is a paucity of information on the combined use of CSII with oral glucose-lowering medications. Learn more about the combination of both of these therapies to overcome insulin resistance and improve glycemic control.

Assessing Alcohol Use Among Patients Receiving Prescribed Opioids
There is no end in sight for the opioid epidemic, as opioid-related deaths continue to rise with 56,516 overdose deaths reported in 2020. One factor that elevates the lethality of opioid consumption is the concomitant use of alcohol. The FDA has issued a warning regarding the concomitant use of alcohol and other sedative medications with opioids. Read more.

Deprescribing Receptiveness in the Community Pharmacy Setting
Much has been written about deprescribing in the institutional setting. However, little is known about patients' willingness and motivating factors for deprescribing in the community pharmacy setting. To help elucidate these factors, researchers conducted a study to assess patients' beliefs and attitudes to identify facilitators of and barriers to deprescribing in the community pharmacy setting. Read more.